NEW YORK – Startup RenalytixAI said on Tuesday that it has partnered with DaVita to slow disease progression and improve health outcomes for US patients with early-stage kidney disease through risk assessments and end-to-end care management.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.